Related Experiment Video
Updated: Jun 4, 2026

07:39
Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels
Published on: January 22, 2019
Assessing matrix metalloproteinase expression and activity in hepatocellular carcinomas
Methods in Molecular Medicine
|February 23, 2011
Summary
Matrix metalloproteinases (MMPs) are enzymes crucial for tissue remodeling in processes like wound healing and tumor invasion. Increased MMP2 and MT1-MMP expression correlates with liver fibrosis and cancer aggressiveness.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Matrix metalloproteinases (MMPs) are zinc- and calcium-dependent endopeptidases that degrade extracellular matrix components.
- MMPs are classified by substrate specificity, including collagenases, gelatinases, and membrane-type MMPs (MT-MMPs).
- MMP activity is regulated by gene expression, proteolytic activation, and inhibition by tissue inhibitors of metalloproteinase (TIMPs).
Purpose of the Study:
- To investigate the role of MMPs in extracellular matrix remodeling.
- To correlate MMP expression levels with pathological conditions such as liver fibrosis and cancer.
- To evaluate MMP activity using gel substrate analysis.
Main Methods:
- Immunohistochemistry, Northern, Western, and dot blots to assess MMP expression.
- Gel substrate analysis to evaluate MMP activity.
- In situ hybridization to determine the cellular sources of MMPs.
Main Results:
- Elevated expression of MMP2, MT1-MMP, TIMP1, and TIMP2 is associated with liver fibrosis.
- High expression of MMP2, MMP9, MT1-MMP, and matrilysin correlates with hepatocellular carcinoma aggressiveness.
- MMP2 activity is increased in primary and secondary liver cancers.
Conclusions:
- MMPs play a significant role in extracellular matrix remodeling during physiological and pathological processes.
- Aberrant MMP expression and activity are linked to the progression of liver fibrosis and hepatocellular carcinoma.
- Further research into MMP regulation may offer therapeutic targets for liver diseases and cancer.